Catalyst Funds Management’s Avidity Biosciences RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,200
Closed -$30.6K 1529
2024
Q1
$30.6K Buy
+1,200
New +$30.6K 0.01% 660